Correlation Between Salesforce and Entia Biosciences

Can any of the company-specific risk be diversified away by investing in both Salesforce and Entia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Entia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Entia Biosciences, you can compare the effects of market volatilities on Salesforce and Entia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Entia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Entia Biosciences.

Diversification Opportunities for Salesforce and Entia Biosciences

0.5

Correlation Coefficient

Salesforce  Entia Biosciences

Very weak diversification

The 3 months correlation between Salesforce and Entia is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Entia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entia Biosciences and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Entia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entia Biosciences has no effect on the direction of Salesforce i.e., Salesforce and Entia Biosciences go up and down completely randomly.

Pair Corralation between Salesforce and Entia Biosciences

Considering the 90-day investment horizon Salesforce is expected to generate 0.29 times more return on investment than Entia Biosciences. However, Salesforce is 3.48 times less risky than Entia Biosciences. It trades about -0.18 of its potential returns per unit of risk. Entia Biosciences is currently generating about -0.13 per unit of risk. If you would invest  34,365  in Salesforce on December 20, 2024 and sell it today you would lose (6,426) from holding Salesforce or give up 18.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	93.65%
Values	Daily Returns

Salesforce  vs.  Entia Biosciences

Salesforce

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Entia Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Entia Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Salesforce and Entia Biosciences

The main advantage of trading using opposite Salesforce and Entia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Entia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will offset losses from the drop in Entia Biosciences' long position.

The idea behind Salesforce and Entia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.